{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:40:02Z","timestamp":1784054402946,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.bioorg.2019.103210","type":"journal-article","created":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T10:53:57Z","timestamp":1566039237000},"page":"103210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Spirocyclic sulfonamides with carbonic anhydrase inhibitory and anti-neuropathic pain activity"],"prefix":"10.1016","volume":"92","author":[{"given":"Y.","family":"Kalisha Vali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rambabu","family":"Gundla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Om V.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasinalli","family":"Tamboli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Di Cesare Manelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ghelardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-Malek S.","family":"Al-Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.103210_b0005","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1021\/np070010e","article-title":"Bioactive compounds from Bauhinia purpurea possessing antimalarial, antimycobacterial, antifungal, anti-inflammatory, and cytotoxic activities","volume":"5","author":"Boonphong","year":"2007","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2019.103210_b0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ejmech.2018.03.001","article-title":"Design, synthesis and anticancer evaluation of novel spirobenzo[h]chromene and spirochromane derivatives with dual EGFR and B-RAF inhibitory activities","volume":"150","author":"Abdelatef","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103210_b0015","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1210\/jcem-19-12-1683","article-title":"The role of potassium in the natriuretic response to a steroidal lactone (SC-9420)","volume":"19","author":"Taylor","year":"1959","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bioorg.2019.103210_b0020","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1021\/cr500127b","article-title":"Four-membered ring-containing spirocycles: synthetic strategies and opportunities","volume":"114","author":"Carreira","year":"2014","journal-title":"Chem. Rev."},{"issue":"8","key":"10.1016\/j.bioorg.2019.103210_b0025","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1021\/jm9018788","article-title":"Oxetanes in drug discovery: structural and synthetic insights","volume":"53","author":"Wuitschik","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103210_b0030","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1016\/j.bmcl.2014.06.081","article-title":"The use of spirocyclic scaffolds in drug discovery","volume":"24","author":"Zheng","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103210_b0035","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejmech.2019.05.058","article-title":"Benzensulfonamides bearing spirohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects","volume":"177","author":"Angeli","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2019.103210_b0040","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/ml500117c","article-title":"Discovery of a potent analgesic NOP and opioid receptor agonist: cebranopadol","volume":"5","author":"Schunk","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103210_b0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1503\/cmaj.060146","article-title":"Neuropathic pain: a practical guide for the clinician","volume":"175","author":"Gilron","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.bioorg.2019.103210_b0050","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioorg.2019.103210_b0055","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pain.2009.11.015","article-title":"Acetazolamide and midazolam act synergistically to inhibit neuropathic pain","volume":"148","author":"Asiedu","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.bioorg.2019.103210_b0060","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpain.2014.01.001","article-title":"Inhibition of carbonic anhydrase augments GABAA receptor-mediated analgesia via a spinal mechanism of action","volume":"15","author":"Asiedu","year":"2014","journal-title":"J. Pain"},{"key":"10.1016\/j.bioorg.2019.103210_b0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejmech.2018.05.026","article-title":"Design, synthesis and X-ray crystallography of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects","volume":"154","author":"Angeli","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2019.103210_b0070","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.bmc.2015.02.027","article-title":"A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects","volume":"23","author":"Carta","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103210_b0075","article-title":"Spiroketone acetyl-coa carboxylase inhibitors","author":"Corbett","year":"2008","journal-title":"WO2008065508"},{"key":"10.1016\/j.bioorg.2019.103210_b0080","doi-asserted-by":"crossref","first-page":"16221","DOI":"10.3390\/molecules200916221","article-title":"Synthesis, biological evaluation and molecular docking studies of piperidinylpiperidines and spirochromanones possessing quinoline moieties as acetyl-CoA carboxylase inhibitors","volume":"20","author":"Huang","year":"2015","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2019.103210_b0085","unstructured":"M. Kamata, K. Fukatsu, T. Yamashita, N. Furuyama, S. Endo, PCT Int. Appl., 2008102749."},{"issue":"8","key":"10.1016\/j.bioorg.2019.103210_b0090","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1021\/jm200146u","article-title":"Discovery, synthesis, and pharmacological evaluation of spiropiperidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitors","volume":"54","author":"Varasi","year":"2011","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2019.103210_b0095","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bmcl.2008.11.099","article-title":"Synthesis of spiro[chroman-2,4'-piperidin]-4-one derivatives as acetyl-CoA carboxylase inhibitors","volume":"19","author":"Shinde","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103210_b0100","unstructured":"U. Ulrich Reiser, O. Kraemer, P. Sennhenn, W. Spevak, Spiro- (tho) benzopyran-2,4'-piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes. WO2007128782, 2007."},{"issue":"19","key":"10.1016\/j.bioorg.2019.103210_b0105","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1021\/jm8008986","article-title":"Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)","volume":"51","author":"Le Bourdonnec","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103210_b0110","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2019.103210_b0115","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1016\/j.bmc.2017.05.014","article-title":"Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors","volume":"25","author":"Angeli","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"48","key":"10.1016\/j.bioorg.2019.103210_b0120","doi-asserted-by":"crossref","first-page":"11353","DOI":"10.1039\/C6OB02299E","article-title":"Intramolecular oxidative deselenization of acylselenoureas: a facile synthesis of benzoxazole amides and carbonic anhydrase inhibitors","volume":"14","author":"Angeli","year":"2016","journal-title":"Org. Biomol. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103210_b0125","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1039\/C8CC08562E","article-title":"Selenols: a new class of carbonic anhydrase inhibitors","volume":"55","author":"Angeli","year":"2019","journal-title":"Chem. Commun. (Camb)."},{"key":"10.1016\/j.bioorg.2019.103210_b0130","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1039\/C8CC09568J","article-title":"Polypharmacology of epacadostat: a potent and selective inhibitor of the tumor associated carbonic anhydrases IX and XII","volume":"55","author":"Angeli","year":"2019","journal-title":"Chem. Commun. (Camb)."},{"key":"10.1016\/j.bioorg.2019.103210_b0135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuropharm.2017.04.029","article-title":"Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: role of Kv7 potassium channels","volume":"121","author":"Di Cesare Mannelli","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bioorg.2019.103210_b0140","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/905360","article-title":"Therapeutic effects of the superoxide dismutase mimetic compound MnIIMe2DO2A on experimental articular pain in rats","volume":"2013","author":"Di Cesare Mannelli","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bioorg.2019.103210_b0145","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1021\/jm901298x","article-title":"A novel manganese complex effective as superoxide anion scavenger and therapeutic agent against cell and tissue oxidative injury","volume":"52","author":"Failli","year":"2009","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520681931243X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520681931243X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:53:07Z","timestamp":1758613987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520681931243X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":29,"alternative-id":["S004520681931243X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103210","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spirocyclic sulfonamides with carbonic anhydrase inhibitory and anti-neuropathic pain activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103210"}}